FDA.reportPublic FDA data

dihydroergotamine 5.2 MG Nasal Powder

RxCUI
2714187
RxNorm name
dihydroergotamine 5.2 MG Nasal Powder
Display name
dihydroergotamine 5.2 MG Nasal Powder
Full name
dihydroergotamine 5.2 MG Nasal Powder
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ATZUMIDIHYDROERGOTAMINE MESYLATESatsuma Pharmaceuticals, Inc.0982a44a-dc0c-75c0-e063-6394a90a6d6c2026-06-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2714187

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0982a44a-dc0c-75c0-e063-6394a90a6d6cdihydroergotamine 5.2 MG Nasal Powder [PSN] · dihydroergotamine 5.2 MG Nasal Powder [SCD] · DHE 5.2 MG Nasal Powder [SY] · dihydroergotamine 5.2 MG (equivalent to dihydroergotamine mesylate 6 MG) Nasal Powder [SY]42These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 194620250508